Return On Equity of Anebulo Pharmaceuticals, Inc. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Anebulo Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • Anebulo Pharmaceuticals, Inc. Return On Equity for the quarter ending 31 Dec 2025 was -75%, a 38% increase year-over-year.
  • Anebulo Pharmaceuticals, Inc. annual Return On Equity for 2025 was -81%, a 42% increase from 2024.
  • Anebulo Pharmaceuticals, Inc. annual Return On Equity for 2024 was -139%, a 72% decline from 2023.
  • Anebulo Pharmaceuticals, Inc. annual Return On Equity for 2023 was -81%, a 110% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Anebulo Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -75% +45% +38% 01 Oct 2025 31 Dec 2025
Q3 2025 -68% +117% +63% 01 Jul 2025 30 Sep 2025
Q2 2025 -81% +58% +42% 01 Apr 2025 30 Jun 2025
Q1 2025 -90% +33% +27% 01 Jan 2025 31 Mar 2025
Q4 2024 -120% -10% -9.3% 01 Oct 2024 31 Dec 2024
Q3 2024 -184% -86% -88% 01 Jul 2024 30 Sep 2024
Q2 2024 -139% -58% -72% 01 Apr 2024 30 Jun 2024
Q1 2024 -123% -49% -67% 01 Jan 2024 31 Mar 2024
Q4 2023 -109% -46% -72% 01 Oct 2023 31 Dec 2023
Q3 2023 -98% -53% -118% 01 Jul 2023 30 Sep 2023
Q2 2023 -81% -42% -110% 01 Apr 2023 30 Jun 2023
Q1 2023 -74% +100% +58% 01 Jan 2023 31 Mar 2023
Q4 2022 -64% +191% +75% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% +360% +89% 01 Jul 2022 30 Sep 2022
Q2 2022 -38% +1077% +97% 01 Apr 2022 30 Jun 2022
Q1 2022 -174% -223% -455% 01 Jan 2022 31 Mar 2022
Q4 2021 -254% 01 Oct 2021 31 Dec 2021
Q3 2021 -405% 01 Jul 2021 30 Sep 2021
Q2 2021 -1116% 01 Apr 2021 30 Jun 2021
Q1 2021 49% 01 Jan 2021 31 Mar 2021

Anebulo Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2025 -81% +58% +42% 01 Jul 2024 30 Jun 2025
2024 -139% -58% -72% 01 Jul 2023 30 Jun 2024
2023 -81% -42% -110% 01 Jul 2022 30 Jun 2023
2022 -38% +1077% +97% 01 Jul 2021 30 Jun 2022
2021 -1116% 01 Jul 2020 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.